Company Overview and News

 
Southern Gold extends farm-in to third South Korean gold project

2018-02-13 proactiveinvestors.com.au
Southern Gold Limited (ASX:SAU) has extended a farm-in and joint venture arrangement with London listed Bluebird Merchant Ventures Ltd (LON:BMV) to encompass a third South Korean gold project.
Upvote Downvote

 
Southern Gold reveals new resource for Cannon gold mine

2017-10-09 proactiveinvestors.com.au
Southern Gold Ltd (ASX:SAU) has revealed a new gold resource for the company’s Cannon gold mine located near Kalgoorlie in Western Australia.
Upvote Downvote

 
Southern Gold Ltd continues to get cash from Cannon gold operations

2017-07-05 proactiveinvestors.com.au
Southern Gold Ltd (ASX:SAU) has received yet another profit share distribution from the company’s Cannon gold mine located southeast of Kalgoorlie in Western Australia’s Eastern Goldfields.
Upvote Downvote

 
Advance of South Korean Objective

2017-06-30 londonstockexchange
Bluebird Merchant Ventures (EPIC:BMV) (Bluebird or The Company) an Asian focused resource development company with gold projects in South Korea and the Philippines announces that Colin Patterson, the CEO of Bluebird has subscribed, on behalf of Bluebird, for AUD250,000  of ASX listed Southern Gold shares at A$0.386 per share. This transaction is in line with the farm-in agreement on the South Korean projects, announced on 27 March 2017 and the management funding announcement on 10 April 2017.
Upvote Downvote

 
Key Permission at Gubong Mine Granted

2017-06-21 londonstockexchange
Bluebird is pleased to announce that the formal procedure granting land access to the Gubong mine in South Korea has been granted today, some 3 weeks earlier than projected.  The permit allows for ingress to the Gubong mine.  In addition, agreement has also been granted by the Government Safety Department on the activity to be undertaken.
Upvote Downvote

 
Southern Gold: Access latest PPT from Proactive's CEO Sessions

2017-04-13 proactiveinvestors.com.au
Southern Gold’s (ASX:SAU) managing director, Simon Mitchell, joined Proactive's CEO Sessions in Melbourne on Tuesday, 11th April and Sydney on Wednesday, 12th April.
Upvote Downvote

 
Director Dealings

2017-04-11 londonstockexchange
Bluebird Merchant Ventures LTD (EPIC: BMV), the South-East Asia focused resource development group announces that it was notified today that Aidan Bishop, Executive Director of the Company, has purchased 1.8 million ordinary shares representing 0.9242 per cent. in the Company ("Ordinary Shares") at 2.0 pence per Ordinary Share.
Upvote Downvote

 
Dimerix brings Phase II clinical trials to Proactive's Spotlight CEO Sessions

2017-04-03 proactiveinvestors.com.au
Dimerix (ASX:DXB) is a clinical stage biotechnology company, with a focus on Phase II clinical trials for chronic kidney disease.
Upvote Downvote

 
Southern Gold’s share from the Cannon gold mine reaches $7.5M

2017-03-28 proactiveinvestors.com.au
Southern Gold (ASX:SAU) has received its fourth profit-share distribution of $2 million from the Cannon gold mine operations in Western Australia.
Upvote Downvote

 
Proteomics International to outline pathway to market at Proactive's CEO Sessions

2017-03-27 proactiveinvestors.com.au
The company continues on a path to commercialisation as it advances deals with partners in Singapore and China to bring its PromarkerD, which is patented in both countries, to the Asian market.
Upvote Downvote

 
Strategy Update and New Acquisition

2017-03-27 londonstockexchange
·      Bluebird enters into an agreement to form a joint venture to reopen two high-grade gold mines in South Korea
Upvote Downvote

 
Southern Gold brings gold production to Proactive's Spotlight CEO Sessions

2017-03-27 proactiveinvestors.com.au
Southern Gold (ASX:SAU) is an under the radar company producing gold near Kalgoorlie through ore agreements with Westgold Resources (ASX:WGX).
Upvote Downvote

 
Proteomics International Laboratories to bring PromarkerD to Asia

2017-03-21 proactiveinvestors.com.au
Proteomics International Laboratories (ASX:PIQ) will advance deals with commercialisation partners in Singapore and China this week to bring PromarkerD to the Asian market.
Upvote Downvote

 
Southern Gold hedges price risk for Cannon gold sale

2017-03-06 proactiveinvestors.com.au
Southern Gold (ASX:SAU) has put in place a hedge for the sale of gold from its Cannon Gold Mine in Western Australia with Japan’s Sumitomo Corporation Global Commodities.
Upvote Downvote

 
Southern Gold starts reaping rewards from Cannon gold mine

2016-12-28 proactiveinvestors.com.au
Southern Gold owns the Bulong Gold Project located 30 kilometres east of Kalgoorlie, which hosts the Cannon Gold Mine, projected to produce around 50,000 ounces gold.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...